ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,043
0,00%
Bitcoin
95.465,87
-1,79%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. NeuroMetrix Inc (NURO)

  7. NeuroMetrix Inc (NURO) News

NURO

NeuroMetrix (NURO)

NeuroMetrix Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NURO
DatumZeitQuelleÜberschriftSymbolFirma
19/12/202416h24Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:NURONeuroMetrix Inc
18/12/202415h03PR Newswire (US)Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law FirmNASDAQ:NURONeuroMetrix Inc
17/12/202423h27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NURONeuroMetrix Inc
17/12/202423h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
17/12/202422h05GlobeNewswire Inc.NeuroMetrix to be Acquired by electroCoreNASDAQ:NURONeuroMetrix Inc
05/11/202422h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
05/11/202416h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
05/11/202413h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
05/11/202413h00GlobeNewswire Inc.NeuroMetrix Reports Q3 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
02/10/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
27/09/202421h56Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NURONeuroMetrix Inc
26/09/202423h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
26/09/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
13/08/202420h47GlobeNewswire Inc.NeuroMetrix Reiterates its Review of Strategic AlternativesNASDAQ:NURONeuroMetrix Inc
06/08/202422h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
06/08/202413h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
06/08/202413h00GlobeNewswire Inc.NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic OptionsNASDAQ:NURONeuroMetrix Inc
31/07/202420h03GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
31/05/202419h15Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NURONeuroMetrix Inc
24/05/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
15/05/202422h00GlobeNewswire Inc.NeuroMetrix Reports Q1 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
15/05/202418h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NURONeuroMetrix Inc
15/05/202417h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
07/05/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
19/04/202414h00GlobeNewswire Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder ValueNASDAQ:NURONeuroMetrix Inc
14/03/202414h00GlobeNewswire Inc.NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral NeuropathyNASDAQ:NURONeuroMetrix Inc
13/03/202414h00GlobeNewswire Inc.NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® FibromyalgiaNASDAQ:NURONeuroMetrix Inc
06/03/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
 Showing the most relevant articles for your search:NASDAQ:NURO

Kürzlich von Ihnen besucht

DBI
SDXP
SDAX
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
NASDAQ
AAPL
Apple
TG
LHA
Deutsche Lufthansa
TG
MBG
MercedesBenz
USOTC
ADDYY
Adidas (QX)
TG
DTE
Deutsche Telekom
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
COIN
ADAUSD
Cardano
DBI
TDXP
Tec DAX
FX
EURGBP
Euro vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten